Olr251 inhibitors represent a class of chemical compounds that are characterized by their specific interaction with the Olr251 receptor, a member of the olfactory receptor family. These inhibitors are designed to modulate the activity of this receptor, which is primarily known for its role in detecting odorant molecules. The Olr251 receptor, like other olfactory receptors, is a G protein-coupled receptor (GPCR), a large and diverse group of membrane proteins that play a crucial role in various physiological processes by transmitting signals from the extracellular environment to the inside of the cell. The structural characteristics of Olr251 inhibitors are typically tailored to fit the binding pocket of the receptor, allowing for precise interactions that can either block or alter the receptor's natural response to its ligands. These interactions are governed by various factors such as hydrogen bonding, hydrophobic interactions, and van der Waals forces, which contribute to the binding affinity and specificity of the inhibitors.
In studying Olr251 inhibitors, researchers focus on the molecular dynamics and conformational changes that occur upon binding. This involves computational modeling and in vitro assays to elucidate the exact mechanism by which these inhibitors affect the receptor's activity. These studies often reveal important insights into the receptor's structure-function relationship and provide a deeper understanding of the molecular underpinnings of olfactory signaling pathways. Furthermore, the development of Olr251 inhibitors requires extensive research into the receptor's ligand-binding domain, where subtle changes in inhibitor structure can lead to significant differences in binding efficacy and selectivity. These findings contribute to a broader knowledge of GPCR function and the complex interactions that govern receptor activation and inhibition, which are fundamental to various biological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $74.00 $166.00 | 2 | |
Calcium channel blocker, can modulate vascular smooth muscle function, potentially impacting Olr251. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $124.00 $240.00 $530.00 $999.00 $1530.00 | 2 | |
Beta-blocker with vasodilating properties, might affect cardiovascular signaling, impacting Olr251. | ||||||
Donepezil | 120014-06-4 | sc-279006 | 10 mg | $74.00 | 3 | |
Acetylcholinesterase inhibitor, could influence neurotransmitter levels, potentially impacting Olr251. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $78.00 $142.00 | 23 | |
Antifungal, can disrupt fungal cell membrane synthesis, potentially impacting Olr251. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Antidiabetic, might modulate glucose metabolism, affecting Olr251. | ||||||
Olanzapine | 132539-06-1 | sc-212469 | 100 mg | $133.00 | 6 | |
Antipsychotic, could affect neurotransmitter pathways, potentially impacting Olr251. | ||||||
Pantoprazole | 102625-70-7 | sc-204830 sc-204830A | 100 mg 500 mg | $89.00 $255.00 | 2 | |
Proton pump inhibitor, may alter gastric acid production, affecting Olr251. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $145.00 | 8 | |
Statin, might influence cholesterol synthesis pathways, impacting Olr251. | ||||||
Valsartan | 137862-53-4 | sc-220362 sc-220362A sc-220362B | 10 mg 100 mg 1 g | $40.00 $92.00 $122.00 | 4 | |
Angiotensin II receptor blocker, may modulate blood pressure and renal function, affecting Olr251. | ||||||